Overview of the 2022 WHO classification of thyroid neoplasms
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Biologic and clinical perspectives on thyroid cancer
JA Fagin, SA Wells Jr - New England Journal of Medicine, 2016 - Mass Medical Soc
Biologic and Clinical Perspectives on Thyroid Cancer | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
Molecular pathogenesis and mechanisms of thyroid cancer
M Xing - Nature Reviews Cancer, 2013 - nature.com
Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …
understanding its molecular pathogenesis in recent years, as best exemplified by the …
New therapies for advanced thyroid cancer
D Laha, N Nilubol, M Boufraqech - Frontiers in endocrinology, 2020 - frontiersin.org
Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer …
DC Shonka Jr, A Ho, AV Chintakuntlawar… - Head & …, 2022 - Wiley Online Library
Background The development of systemic treatment options leveraging the molecular
landscape of advanced thyroid cancer is a burgeoning field. This is a multidisciplinary …
landscape of advanced thyroid cancer is a burgeoning field. This is a multidisciplinary …
Molecular genetics and diagnosis of thyroid cancer
YE Nikiforov, MN Nikiforova - Nature Reviews Endocrinology, 2011 - nature.com
Thyroid cancer is a common type of endocrine malignancy, and its incidence has been
steadily increasing in many regions of the world. Initiation and progression of thyroid cancer …
steadily increasing in many regions of the world. Initiation and progression of thyroid cancer …
Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion …
YE Nikiforov, SE Carty, SI Chiosea, C Coyne… - Thyroid, 2015 - liebertpub.com
Background: Fine-needle aspiration (FNA) cytology is a common approach to evaluate
thyroid nodules. It offers definitive diagnosis of a benign or malignant nodule in the majority …
thyroid nodules. It offers definitive diagnosis of a benign or malignant nodule in the majority …
Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer
MN Nikiforova, AI Wald, S Roy… - The Journal of …, 2013 - academic.oup.com
Objectives: Next-generation sequencing (NGS) allows for high-throughput sequencing
analysis of large regions of the human genome. We explored the use of targeted NGS for …
analysis of large regions of the human genome. We explored the use of targeted NGS for …
Novel targeted therapies and immunotherapy for advanced thyroid cancers
Thyroid cancer is a frequently encountered endocrine malignancy. Despite the favorable
prognosis of this disease, 15–20% of differentiated thyroid cancer (DTC) cases and most …
prognosis of this disease, 15–20% of differentiated thyroid cancer (DTC) cases and most …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer
P Fallahi, SM Ferrari, MR Galdiero, G Varricchi… - Seminars in cancer …, 2022 - Elsevier
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …